-
Non-invasive assessment of endothelial function in normal pregnancy.
Savvidou MD, Kametas NA, Donald AE, Nicolaides KH.
Ultrasound Obstet Gynecol 2000;15:502-7. -
The relationship between leptin concentration and bone metabolism in the human fetus.
Ogueh O, Sooranna S, Nicolaides KH, Johnson MR.
J Clin Endocrinol Metab 2000;85:1997-9. -
The feto-placental unit stimulates the pregnancy-associated increase in maternal bone metabolism.
Ogueh O, Khastgir G, Abbas A, Jones J, Nicolaides KH, Studd JW, Alaghband-Zadeh J, Johnson MR.
Hum Reprod 2000;15:1834-7. -
Insulin-like growth factor binding protein-1 (IGFBP-1): a multifunctional role in the human female reproductive tract.
Fowler DJ, Nicolaides KH, Miell JP.
Hum Reprod Update 2000;6:495-504. -
Maternal age and gestation-specific risk for trisomy 21.
Snijders RJ, Sundberg K, Holzgreve W, Henry G, Nicolaides KH.
Ultrasound Obstet Gynecol 1999;13:167-70. -
Maternal serum S100 protein in normal and Down syndrome pregnancies.
Abraha HD, Noble PL, Nicolaides KH, Sherwood RA.
Prenat Diagn 1999;19:334-6. -
Collagen type VI gene expression in the skin of trisomy 21 fetuses.
von Kaisenberg CS, Brand-Saberi B, Christ B, Vallian S, Farzaneh F, Nicolaides KH.
Obstet Gynecol 1998;91:319-23. -
UK multicentre project on assessment of risk of trisomy 21 by maternal age and fetal nuchal-translucency thickness at 10-14 weeks of gestation.
Snijders RJ, Noble P, Sebire N, Souka A, Nicolaides KH.
Lancet 1998;352:343-6. -
Maternal and fetal insulin-like growth factors and their binding proteins in the second and third trimesters of human pregnancy.
Langford K, Nicolaides K, Miell JP.
Hum Reprod 1998;13:1389-93. -
Biochemical analyses of mesenchymal fluid in early pregnancy.
Jauniaux E, Gulbis B, Hyett J, Nicolaides KH.
Am J Obstet Gynecol 1998;178:765-9. -
First trimester urine free beta hCG, beta core, and total oestriol in pregnancies affected by Down's syndrome: implications for first-trimester screening with nuchal translucency and serum free beta hCG.
Spencer K, Noble P, Snijders RJ, Nicolaides KH.
Prenat Diagn 1997;17:525-38. -
Maternal serum inhibin-A and free beta-hCG concentrations in trisomy 21 pregnancies at 10-14 weeks of gestation.
Noble PL, Wallace EM, Snijders RJ, Groome NP, Nicolaides KH.
BJOG 1997;104:367-71. -
Down's syndrome screening with nuchal translucency.
Nicolaides KH, Sebire NJ, Snijders RJ.
Lancet 1997;349:438. -
Screening for trisomy 21 in twin pregnancies by maternal age and fetal nuchal translucency thickness at 10-14 weeks of gestation.
Sebire NJ, Snijders RJM, Hughes K, Sepulveda W, Nicolaides KH.
BJOG 1996;103:999-1003. -
Down's syndrome screeening in the UK.
Nicolaides KH, Sebire NJ, Snijders RJ, Johnson S, Reynolds TM.
Lancet 1996;347:906-7. -
Evolution of maternofetal transport of immunoglobulins during human pregnancy.
Malek A, Sager R, Kuhn P, Nicolaides KH, Schneider H.
Am J Reprod Immunol 1996;36:248-55. -
Intrauterine lethality of trisomy 21 fetuses with increased nuchal translucency.
Hyett JH, Sebire NJ, Snijders RJM, Nicolaides KH.
Ultrasound Obstet Gynecol 1996;7:101-3. -
Essential fatty acid status of fetal plasma phospholipids: Similar to postnatal values obtained at comparable gestational ages.
Foreman-van Drongelen MM, von Houwelingen AC, Nicolini U, Nicolaides KH, Al MDM, Kester ADM, Hornstra G.
Early Hum Dev 1996;46:141-52. -
Changes in maternal plasma macrophage-colony stimulating factor levels during normal pregnancy.
Tsakonas DP, Nicolaides KH, Tsakona CP, Worman CP, Goldstone AH.
Clin Lab Haematol 1995;17:57-9. -
Neutrophil and monocyte beta 2-integrin expression in maternal and fetal blood.
Thilaganathan B, Makrydimas G, Plachouras N, Nicolaides KH.
Am J Obstet Gynecol 1995;172:58-62.